This site is intended for health professionals only
A Venous Thromboembolism (VTE) is a clot, which has formed in a vein, usually the deep veins in the leg. It most commonly starts in the calf veins but can extend up into the thigh veins; this condition is known as Deep Vein Thrombosis (DVT). 1
DVT affects approximately 1 in every 1,000 of the UK population and each year, more than 140,000 persons present to primary care with signs and symptoms suggestive of DVT.2 VTE is one of the most significant causes of avoidable illness and mortality, and its treatment and management costs the NHS £640 million every year.3
D-Dimer testing is used as an aid in the diagnosis of venous thromboembolism (VTE) and is widely accepted as the first-step in the management of patients with suspected VTE.4 Point of care D-Dimer testing is recommended by NICE when used in conjunction with the Wells clinical risk score.5 The LumiraDx D-Dimer Test provides results within 6 minutes from a fingerstick sample, providing fast, accurate results, at the point of care.
References: 1. Thrombosis UK. VTE General Overview Leaflet. https://thrombosisuk.org/admin/resources/downloads/tuk-a4-vte-general-leaflet-final.pdf. 2. Büller, H., 2009. Safely Ruling Out Deep Venous Thrombosis in Primary Care. Annals of Internal Medicine, 150(4), p.229. 3. The All-Party Parliamentary Thrombosis Group (APPTG). Annual Review. November 2017. 4. Rodger MA, Le Gal G, Wells P et al. Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Throm Res 2014; 134,4: 763-68 5. National Institute of Clinical Excellence (NICE). 2020. NG158. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing.